Petar M. Seferovic
Petar Seferovic is Vice-president of The European Society of Cardiology and Immediate past-President of the Heart Failure Association of the European Society of Cardiology. He is a Professor at University of Belgrade Faculty of Medicine, full member of Serbian Academy of Sciences and Arts and President of Heart Failure Society of Serbia. Prof. Seferovic has a long standing experience in the activities of ESC, and later was involved in Heart Failure Association projects for almost a decade.
After completing his training and fellowship at Belgrade University School of Medicine and Kings College Hospital in London, UK, he spent two years as a Visiting Assistant professor in Methodist Hospital and Baylor College of Medicine, Houston, USA. Prof. Seferović was leading the introduction of several methods of interventional cardiology and myocardial and pericardial disease in Serbia, including percutaneous transluminal angioplasty, endomyocardial biopsy, percutaneous pericardioscopy and pericardial biopsy. Starting in the mid-90's, he dedicated his clinical and research activity to chronic and acute heart failure.
His research interests mainly include heart failure (acute and chronic), cardiovascular disease (heart failure) and diabetes, as well as cardiomyopathies, myocarditis and pericardial disease. He has been involved in numerous heart failure clinical trials as a National coordinator and Principal investigator, member of international steering committees, endpoint committees, and advisory boards.
Prof. Seferović has coauthored a total of 606 publications, with cumulative impact factor of 1078 (h-index 36), including multiple papers in peer-reviewed international journals. He has a total citation of 17833 (Google Scholar) / 14298 (Scopus). He presented more than 260 lectures at International conferences.
He acted as a Task Force member on several ESC guidelines, including ESC guidelines on the diagnosis and treatment of acute and chronic heart failure, the ESC guidelines for the management of pericardial disease, and the guidelines on cardiovascular diseases in diabetes. In addition, Petar Seferovic serves as a reviewer for several journals.